This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Mar 27;115(12):1634-42.

doi: 10.1161/CIRCULATIONAHA.106.181424. Epub 2007 Feb 26.

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

Elliott M Antman¹, Joel S Bennett, Alan Daugherty, Curt Furberg, Harold Roberts, Kathryn A Taubert; American Heart Association

Affiliations

PMID: 17325246
DOI: 10.1161/CIRCULATIONAHA.106.181424

Review

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

Elliott M Antman et al. Circulation. 2007.

. 2007 Mar 27;115(12):1634-42.

doi: 10.1161/CIRCULATIONAHA.106.181424. Epub 2007 Feb 26.

Authors

Elliott M Antman¹, Joel S Bennett, Alan Daugherty, Curt Furberg, Harold Roberts, Kathryn A Taubert; American Heart Association

Affiliation

¹ Brigham and Women's Hospital, Harvard Medical School, USA.

PMID: 17325246
DOI: 10.1161/CIRCULATIONAHA.106.181424

No abstract available

PubMed Disclaimer

Similar articles

Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic, antiinflammatory drugs? Arguments against.
Weber AA, Hohlfeld T, Harder S. Weber AA, et al. Thromb Haemost. 2006 Oct;96(4):413-6. Thromb Haemost. 2006. PMID: 17003916 Review.
[Analgesics, NSAIDS, and coxibs in rheumatic pain].
Di Matteo L. Di Matteo L. Reumatismo. 2006 Jan-Mar;58 Spec No.1:84-9. Reumatismo. 2006. PMID: 23631071 Italian. No abstract available.
Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
Vardeny O, Solomon SD. Vardeny O, et al. Cardiol Clin. 2008 Nov;26(4):589-601. doi: 10.1016/j.ccl.2008.06.004. Cardiol Clin. 2008. PMID: 18929233
Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.
Moore RA, Derry S, McQuay HJ. Moore RA, et al. BMC Musculoskelet Disord. 2007 Aug 3;8:73. doi: 10.1186/1471-2474-8-73. BMC Musculoskelet Disord. 2007. PMID: 17683540 Free PMC article.
[Safe prescription recommendations for non steroidal anti-inflammatory drugs: Consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG)].
Lanas A, Benito P, Alonso J, Hernández-Cruz B, Barón-Esquivias G, Perez-Aísa A, Calvet X, García-Llorente JF, Gobbo M, Gonzalez-Juanatey JR. Lanas A, et al. Gastroenterol Hepatol. 2014 Mar;37(3):107-27. doi: 10.1016/j.gastrohep.2013.11.014. Epub 2014 Feb 14. Gastroenterol Hepatol. 2014. PMID: 24529572 Spanish.

See all similar articles

Cited by

Comprehensive evaluation of ibuprofenate amino acid isopropyl esters: insights into antioxidant activity, cytocompatibility, and cyclooxygenase inhibitory potential.
Perużyńska M, Nowak A, Muzykiewicz-Szymańska A, Kucharski Ł, Klebeko J, Bilska K, Kopciuch E, Birger R, Droździk M, Ossowicz-Rupniewska P. Perużyńska M, et al. Pharmacol Rep. 2024 Oct 19. doi: 10.1007/s43440-024-00666-6. Online ahead of print. Pharmacol Rep. 2024. PMID: 39425885
Is fluid retention a cardiovascular risk factor?
Blankfield RP. Blankfield RP. Clin Hemorheol Microcirc. 2024;88(2):277-288. doi: 10.3233/CH-242128. Clin Hemorheol Microcirc. 2024. PMID: 39302357 Free PMC article. Review.
Renal effects of selective cyclooxygenase-2 inhibitor anti-inflammatory drugs: A systematic review and meta-analysis.
Biase TMMA, Rocha JGM, Silva MT, Ribeiro-Vaz I, Galvão TF. Biase TMMA, et al. Explor Res Clin Soc Pharm. 2024 Jul 8;15:100475. doi: 10.1016/j.rcsop.2024.100475. eCollection 2024 Sep. Explor Res Clin Soc Pharm. 2024. PMID: 39114538 Free PMC article. Review.
Degree of Cyclooxygenase-2 Inhibition Modulates Blood Pressure Response to Celecoxib and Naproxen.
Theken KN, Ghosh S, Skarke C, Fries S, Lahens NF, Sarantopoulou D, Grant GR, FitzGerald GA, Grosser T. Theken KN, et al. medRxiv [Preprint]. 2024 May 31:2024.05.30.24308244. doi: 10.1101/2024.05.30.24308244. medRxiv. 2024. PMID: 38854091 Free PMC article. Preprint.
Imrecoxib: Advances in Pharmacology and Therapeutics.
Wang YH, Zhu LL, Li TL, Zhou Q. Wang YH, et al. Drug Des Devel Ther. 2024 May 22;18:1711-1725. doi: 10.2147/DDDT.S464485. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38799798 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information